Protek PAO operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Protek PAO with three other
pharmaceutical manufacturers in Europe:
H. Lundbeck A/S
sales of 18.12 billion Danish Kroner [US$2.69 billion]
of which 100%
(2.35 billion Euro [US$2.60 billion]
of which 82%
was Specialty Care), and
Stada Arzneimittel AG
based in Germany
(2.33 billion Euro [US$2.58 billion]
of which 59%
During the year ended December of 2018, sales at
Protek PAO were 251.73 billion Russian Rubles (US$3.95 billion).
decrease of 2.6%
versus 2017, when the company's sales were 258.45 billion Russian Rubles.
Contributing to the drop in overall sales was the 9.5% decline
in Distribution, from 201.43 billion Russian Rubles to 182.35 billion Russian Rubles.
However, these declines were partially offset by the increase in sales of
Retail Sales (up 23.6% to 61.53 billion Russian Rubles)
Production (up 8.0% to 7.86 billion Russian Rubles)